Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: A single centre experience

British Journal of Haematology

Volumn 146, Issue 5, 2009, Pages 574-576

  Tsitsikas, Dimitris A ^a   Oakervee, Heather ^a   Cavenagh, Jamie D ^a   Gribben, John ^a   Agrawal, Samir G ^a   Mattes, Frank M ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Haemopoietic stem cell transplantation; Palivizumab; Respiratory syncytial virus; Ribavirin

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B LIPID COMPLEX; ANTIINFECTIVE AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; PALIVIZUMAB; RIBAVIRIN; STEROID; VORICONAZOLE;

ABSENCE OF SIDE EFFECTS; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; IMMUNOFLUORESCENCE; LARGE CELL LYMPHOMA; LETTER; LUNG LAVAGE; MULTIPLE MYELOMA; MYCOSIS; NASOPHARYNGEAL ASPIRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS INFECTION; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RIBAVIRIN;

EID: 68949210743     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07763.x     Document Type: Letter

References (9)

1. Boeckh, M., Berrey, M.M., Bowden, R.A., Crawford, S.W., Balsley, J. Corey, L. (2001) Phase I Evaluation of the Respiratory Syncytial Virus-Specific Monoclonal Antibody Palivizumab in Recipients of Hematopoietic Stem Cell Transplants. The Journal of Infectious Diseases, 184, 350 354.
2. Boeckh, M., Rnglund, J., Li, Y., Miller, C., Cross, A., Frnandez, H., Kuypers, J., Kim, H., Gnann, J. Whtitley, R. (2007) Randomized Controlled Multicenter trial of Aerosolized Ribavirin for Respiratory Syncytial Virus Upper Respiratory Tract infection in Hematopoietic Cell Transplant Recipients. Clinical Infectious Diseases, 44, 245 249.
3. Champlin, R.E. Whimbey, E. (2001) Community Respiratory Virus Infections in Bone Marrow Transplant Recipients: The M.D. Anderson Cancer Center Experience. Biology of Blood and Marrow Transplantation, 7, 8S 10S.
4. Chavez-Bueno, S., Mejias, A., Merryman, R.A., Ahmad, N., Jafri, H. Ramilo, O. (2007) Intravenous Palivizumab and Ribavirin Combination for Respiratory Syncytial Virus Disease in High-Risk Pediatric Patients. The Pediatric Infectious Disease Journal, 26, 1089 1093.
5. Fontbrune de, F.S., Robin, M., Porcher, R., Scieux, C., Latour de, R.P., Ferry, C., Rocha, V., Boudjedir, K., Devergie, A., Bergeron, A., Gluckman, E., Azoulay, E., Lapalu, J., Socie, G. Ribaud, P. (2007) Palivizumab Treatment of Respiratory Syncytial Virus Infection after Hematopoietic Stem Cell Transplantation. Clinical Infectious Diseases, 45, 1019 1024.
6. Impact-RSV Study Group (1998) Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants. Pediatrics, 102 (3 531 537.
7. Nichols, W.G., Cooley, T. Boeckh, M. (2001) Community-Acquired Respiratory Syncytial Virus and Parainfluenza Virus Infections Agter Hematopoietic Stem Cell Transplantation: The Fred Hutchinson Cancer Research Center Experience. Biology of Blood and Marrow Transplantation, 7, 11S 15S.
8. Thomas, N.J., Hollenbeak, C.S., Ceneviva, G.D., Geskey, J.M. Young, M.J. (2007) Palivizumab Prophylaxis to Prevent Respiratory Syncytial Virus Mortality After Pediatric Bone Marrow Transplantation. A Decision Analysis Model. Journal of Pediatric Hematology Oncology, 29, 227 232.
9. Wingard, J.R., Nichols, W.G. McDonald, G.B. (2004) Supportive Care. Hematology. American Society of Hematology Education Program, 2004, 372 389.